The Medical Drug as a Technological Object

Techné: Research in Philosophy and Technology 23 (1):51-67 (2019)
  Copy   BIBTEX

Abstract

This article considers the medical drug as a technological object, in order to determine what philosophy of technology can bring to the study of pharmaceuticals and what the study of medical drugs can bring to the philosophy of technology. This approach will allow us to locate the differences between the medical drug and other objects that usually form the focus for studies in the philosophy of technology, and to discuss the problematic fit of the models proposed in the field to pharmaceuticals. After reflecting on the origins of this problem in both the philosophy of pharmacy and the philosophy of technology, I propose an examination of medical drugs using an analytical schema developed by Andrew Feenberg. I expose several shortcomings of this ‘post-phenomenological’ philosophy of technology applied to medical drugs. Despite the various problems identified, I nevertheless argue that the philosophy of technology is useful for thinking about medical drugs, particularly because of the emphasis it places on the social and political dimensions of technology. In conclusion, I argue in favour of a more open, eclectic philosophical engagement with medical drugs that puts more emphasis on their economic, social and political dimensions.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

The Medical Drug as a Technological Object.Jonathan Simon - 2019 - Techné: Research in Philosophy and Technology 23 (1):51-67.
Expert and non-expert knowledge in medical practice.Ingemar Nordin - 2000 - Medicine, Health Care and Philosophy 3 (3):295-302.
Informed Consent in the Fields of Medical Technological Practice.Lotte Asveld - 2006 - Techné: Research in Philosophy and Technology 10 (1):16-29.
Race, Pharmacogenomics, and Marketing: Putting BiDil in Context.Jonathan Kahn - 2006 - American Journal of Bioethics 6 (5):W1-W5.

Analytics

Added to PP
2019-05-31

Downloads
30 (#521,181)

6 months
2 (#1,240,909)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Jonathan Simon
Tulane University

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references